San Francisco, CA—Percutaneous closure of the patent ductus arteriosus (PDA) in children using a novel device is safe and effective, according to a prospective study presented in a featured clinical ...

Abbott announced that the FDA approved a closure device for the treatment of premature babies with patent ductus arteriosus who are nonresponsive to medical management. The Amplatzer Piccolo occluder ...

New innovative capability brings lifesaving cardiac care directly to the NICU, reducing risks associated with transporting fragile premature infants. MIAMI , Sept. 22, 2025 /PRNewswire/ -- Nicklaus ...

New Delhi: Doctors at Fortis Escorts Heart Institute, Okhla successfully conducted a rare procedure to save the life of a 1.5-month-old newborn weighing mere 1.8 kgs, who was suffering from patent ...

PDA closure devices are the medical devices to cure congenital heart condition called patent ductus arteriosus (PDA). Patent ductus arteriosus is the opening in between two major blood vessels leading ...

The National Institute for Clinical Excellence is examining endovascular closure of patent ductus arteriosus and will publish guidance on its safety and efficacy to the NHS in England, Wales and ...

We report a case of an 8-month-old girl admitted to the Department of Paediatric Cardiac Surgery, Pomeranian Centre of Traumatology in Gdansk with migration of an Amplatzer Duct Occluder II device ...

KUALA LUMPUR, Malaysia, June 6, 2025 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL) marked a significant milestone in cardiovascular care with the successful transcatheter device occlusion of a ...

PDA closure devices are the medical devices to cure congenital heart condition called patent ductus arteriosus (PDA). Patent ductus arteriosus is the opening in between two major blood vessels leading ...